X antigen family member 1 (21-29)

X antigen family member 1 (21-29) is a synthetic peptide corresponding to amino acids 21 through 29 of the X antigen family member 1 protein. As a defined peptide fragment, it serves as a valuable molecular tool in the study of antigenic determinants and immune recognition. The sequence-specific nature of this peptide allows for targeted investigations into protein-protein interactions, epitope mapping, and the biochemical characterization of antigenic sites. Its relevance extends to research areas involving immunology, peptide-based assay development, and the elucidation of structure-function relationships within the broader X antigen family.

Epitope Mapping: In immunological research, the 21-29 fragment is frequently employed to identify and characterize linear B-cell or T-cell epitopes within the X antigen family. By using this peptide in binding assays or with monoclonal antibody panels, researchers can pinpoint the specific amino acid residues responsible for immune recognition. This targeted approach is instrumental in advancing the understanding of antigen-antibody interactions, facilitating the development of more precise immunoassays, and supporting the rational design of diagnostic reagents.

Peptide-Based Assay Development: The defined sequence of the 21-29 region enables its use as a standard or control in various immunoassays, such as ELISA or western blotting. Incorporating this peptide into assay platforms provides a reliable means to calibrate detection systems, validate antibody specificity, and assess assay sensitivity. Such applications are critical in ensuring the reproducibility and robustness of experimental results, particularly when studying the immunogenicity or expression patterns of X antigen family proteins.

Protein-Protein Interaction Studies: As a functional peptide fragment, the 21-29 sequence can be used to probe direct interactions with other biomolecules, including receptors, binding partners, or regulatory proteins. By employing techniques such as peptide pull-down assays or surface plasmon resonance, researchers can delineate the molecular interfaces that mediate biologically relevant contacts. These studies contribute to a deeper mechanistic understanding of signaling pathways and cellular processes modulated by the X antigen family.

Structural and Biophysical Analysis: The 21-29 peptide serves as a model system for investigating the conformational properties of short protein segments. Its amenability to techniques such as NMR spectroscopy, circular dichroism, or crystallography allows for detailed examination of secondary structure, flexibility, and solvent accessibility. Insights gained from these analyses inform broader structure-function studies, guiding the interpretation of full-length protein behavior and supporting rational mutagenesis efforts.

Immunogenicity Research: The peptide fragment is also utilized to assess the immunogenic potential of specific sequences within the X antigen family. By incorporating it into in vitro stimulation assays or using it as an immunogen in animal models, scientists can evaluate T-cell activation, cytokine production, or antibody generation. These experiments provide foundational data for vaccine design, epitope prioritization, and the identification of immunodominant regions—a critical step in translational immunology and antigen discovery workflows.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. The spatiotemporal control of signalling and trafficking of the GLP-1R

3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes